Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 31:15:1403018.
doi: 10.3389/fimmu.2024.1403018. eCollection 2024.

Chromatin as alarmins in necrotizing enterocolitis

Affiliations
Review

Chromatin as alarmins in necrotizing enterocolitis

Colleen P Nofi et al. Front Immunol. .

Abstract

Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease primarily affecting premature neonates, marked by poorly understood pro-inflammatory signaling cascades. Recent advancements have shed light on a subset of endogenous molecular patterns, termed chromatin-associated molecular patterns (CAMPs), which belong to the broader category of damage-associated molecular patterns (DAMPs). CAMPs play a crucial role in recognizing pattern recognition receptors and orchestrating inflammatory responses. This review focuses into the realm of CAMPs, highlighting key players such as extracellular cold-inducible RNA-binding protein (eCIRP), high mobility group box 1 (HMGB1), cell-free DNA, neutrophil extracellular traps (NETs), histones, and extracellular RNA. These intrinsic molecules, often perceived as foreign, have the potential to trigger immune signaling pathways, thus contributing to NEC pathogenesis. In this review, we unravel the current understanding of the involvement of CAMPs in both preclinical and clinical NEC scenarios. We also focus on elucidating the downstream signaling pathways activated by these molecular patterns, providing insights into the mechanisms that drive inflammation in NEC. Moreover, we scrutinize the landscape of targeted therapeutic approaches, aiming to mitigate the impact of tissue damage in NEC. This in-depth exploration offers a comprehensive overview of the role of CAMPs in NEC, bridging the gap between preclinical and clinical insights.

Keywords: CAMPs; HMGB1; PRRs; TLR4; cell-free DNA; eCIRP; inflammation; necrotizing enterocolitis.

PubMed Disclaimer

Conflict of interest statement

The authors CN, MA, and PW are inventors of the pending PCT application on “A chimeric molecule to treat septic patients”; EFS ID: 47240580; Application No.: 63433789. The remaining author declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
CAMPs, PRRs, and the Development of NEC. CAMPs, including eCIRP, cfDNA, exRNA, HMGB1, histones, and NETs are released upon cellular stress. CAMPs are recognized and activate downstream PRR pathways including TLRs (especially TLR4 and TLR9), cGAS-STING, RAGE, RIG-1, AIM2, and NLRP3. Activation of immune sensors leads to release of pro-inflammatory mediators and causes intestinal inflammation, enterocyte injury and cell death, intestinal barrier dysfunction, bacterial translocation, and impaired microcirculation, all contributing to NEC development. CAMP, chromatin-associated molecular patter; PRR, pattern recognition receptor; NEC, necrotizing enterocolitis; eCIRP, extracellular cold-inducible RNA binding protein; cfDNA, cell-free DNA; exRNA, extracellular RNA; mtDNA, mitochondrial DNA; HMGB1, high mobility group box 1; NETs, neutrophil extacellular traps; TLR, toll-like receptor; TREM-1, triggering receptor expressed on myeloid cells-1; RAGE, receptor for advanced glycation end-products; cGAS, cyclic GMP-AMP (cGAS), STING, stimulator of interferon genes; RIG-1, retinoic acid-inducible gene-I; AIM2, absent in melanoma-2; NLRP3, nod-like receptor family pyrin domain containing-3.

References

    1. Neu J, Walker WA. Necrotizing enterocolitis. New Engl J Med. (2011) 364:255–64. doi: 10.1056/NEJMra1005408 - DOI - PMC - PubMed
    1. Hu X, Liang H, Li F, Zhang R, Zhu Y, Zhu X, et al. . Necrotizing enterocolitis: current understanding of the prevention and management. Pediatr Surg Int. (2024) 40:32. doi: 10.1007/s00383-023-05619-3 - DOI - PMC - PubMed
    1. Jones IH, Hall NJ. Contemporary outcomes for infants with necrotizing enterocolitis—a systematic review. J pediatrics. (2020) 220:86–92. e3. doi: 10.1016/j.jpeds.2019.11.011 - DOI - PubMed
    1. Cho SX, Rudloff I, Lao JC, Pang MA, Goldberg R, Bui CB, et al. . Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities. Nat Commun. (2020) 11:5794. doi: 10.1038/s41467-020-19400-w - DOI - PMC - PubMed
    1. Niño DF, Sodhi CP, Hackam DJ. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol hepatology. (2016) 13:590–600. doi: 10.1038/nrgastro.2016.119 - DOI - PMC - PubMed